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Human induced pluripotent stem cells (hiPSCs) have
been generated by reprogramming a number of dif-
ferent somatic cell types using a variety of ap-
proaches. In addition, direct reprogramming of
mature cells fromone lineage to another hasemerged
recently as an alternative strategy for generating
cell types of interest. Here we show that a combina-
tion of a microRNA (miR-124) and two transcrip-
tion factors (MYT1L and BRN2) is sufficient to
directly reprogram postnatal and adult human
primary dermal fibroblasts (mesoderm) to functional
neurons (ectoderm) under precisely defined condi-
tions. These human induced neurons (hiNs) exhibit
typical neuronal morphology and marker gene ex-
pression, fire action potentials, and produce func-
tional synapses between each other. Our findings
have major implications for cell-replacement strate-
gies in neurodegenerative diseases, disease model-
ing, and neural developmental studies.
The differentiated cell state is often considered stable and resis-
tant to changes in lineage identity. However, challenging this
view, differentiated somatic cell types from humans and other
organisms have been reprogrammed to the pluripotent state
by forced expression of a set of transcription factors (Takahashi
et al., 2007), somatic cell nuclear transfer (Campbell et al., 1996;
Gurdon et al., 1958), or cell fusion (Cowan et al., 2005; Tada
et al., 2001). Additionally, by lineage reprogramming through
ectopic expression of selected genes or cell fusion, a few studies
have demonstrated that an adult cell type can be directly con-
verted to another adult cell type (Cobaleda et al., 2007; Davis
et al., 1987; Feng et al., 2008; Ieda et al., 2010; Zhou et al.,
2008; Zhou andMelton, 2008). However, all these studies involve
conversion of one cell type to another within the same lineage,
a major limitation for many applications. For cell-replacement
therapies, the idea of reprogramming across lineages is fasci-
nating because of its potential to rapidly generate a variety of
therapeutically important and immunologically matched cell
types directly from one’s own easily accessible tissues, suchas skin or blood. In this context, Vierbuchen et al. (2010) demon-
strated that differentiated mouse cells have the capacity for
changing lineage by showing direct conversion of dermal fibro-
blasts to functional ‘‘induced neurons’’ (iNs). Recently, the
same group extended these findings to human fetal and post-
natal fibroblasts to produce human iN (hiN) cells (Pang et al.,
2011). Nonetheless, these hiNs formed functional synapses
only when cocultured with mature mouse cortical neurons,
which potentially provided additional differentiation factors.
Here we show that a combination of a microRNA (miR-124)
and two transcription factors (MYT1L and BRN2) is sufficient to
directly reprogram postnatal and adult human primary dermal
fibroblasts (mesoderm) to functional neurons (ectoderm) under
precisely defined conditions without a requirement for ‘‘helper’’
cells from a different species. These hiNs exhibit typical neuronal
morphology and marker gene expression, fire action potentials,
and form functional synapses.
Given the known critical roles of specific transcription factors,
signaling molecules, and microRNAs in neuronal lineage deter-
mination during development or cell fate regulation, we selected
11 transcription factors (Table S1 available online) and a micro-
RNA (miR-124) to test for their ability to convert primary post-
natal human fibroblasts, BJ or CRL2097, to functional neurons.
After confirming the absence of any contaminating neural or
neuronal cells in BJ and CRL2097 cell cultures by immunostain-
ing (Figure S1A available online) and RT-PCR (Figure S1B), we
transduced them with lentiviruses carrying the 12 factors pooled
together (12F pool, with equal representation of each). The
subsequent culture conditions are depicted in the schematic
diagram in Figure 1A and in the Supplemental Experimental
Procedures section. Infected cells were monitored by the pres-
ence of red fluorescent protein (RFP) coexpressed with the
miRNA vector (pLemiR). Immunocytochemistry for the early
neuronal marker bIII-tubulin (Tuj1), performed 18 days after
infection, revealed a few Tuj1/RFP double-positive cells that
manifested typical neuronal morphology in the 12F-infected
cultures (Figure 1B), while no such cells were observed in
uninfected or GFP-control cultures (Figures S1A and S1C).
These findings suggested that at least some of the factors in
the 12F pool had the capacity to convert fibroblasts to human
neuronal-like cells.
To test whether any single factor among the 12F pool was
sufficient to induce the neuronal phenotype, we transduced BJCell Stem Cell 9, 113–118, August 5, 2011 ª2011 Elsevier Inc. 113
Figure 1. Conversion of Postnatal Human Dermal Fibroblasts to hiN Cells using Defined Factors under Defined Conditions
(A) Schematic showing the experimental protocol.
(B) Tuj1-stained hiN cells 18 days after infection of BJ cells with the 12F pool.
(C) Within 3 days of infection, 3F (miBM)-transduced fibroblasts exhibited notable morphological changes and weak immunoreactivity with Tuj1 antibody.
(D) Time-lapse live images of RFP+ BJ cells infected with miBM showed gradual changes leading to neuronal-like morphology.
(E) 3F-infected BJ cells were Tuj1+ and exhibited characteristic neuronal morphology when stained 240 hr (10 days) after infection.
(F–H) By day 18, hiN cells expressed, in addition to Tuj1 (F), mature neuronal markers, including MAP2 (G) and NeuN (H).
(I) Control cultures infected with BM transgenes along with nonspecific scrambled RNA did not generate hiN cells or show immunoreactivity to Tuj1 antibody.
Red: RFP; green: Tuj1 (B, C, E, F, and I), MAP2 (G), or NeuN (H); blue: DAPI. Scale: 20 mm. See also Figure S1 and Table S1.
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cultures displayed cells with distinctive neuronal morphology,
in cultures transduced with miR-124 alone we observed a few
Tuj1-positive cells with multiple, small processes that resembled
neurites emanating from the soma (Figures S1D and S1E).
However, even after continued culturing for over 1 month, these
cells did not mature further to produce a characteristic neuronal
phenotype (data not shown). Such changes resembled those
observed previously when miR-124 was overexpressed in non-
neuronal cells (Yu et al., 2008).
Next, we tested two-factor combinations and found that
cultures transduced with miR-124 plus BRN2 (designated miB)
or PAX 6 (miP) exhibited cells that were morphologically similar
to those observed with miR-124 alone, but with >20-fold better
efficacy (Figure S1F). Cells infected with miR-124 plus MYT1L
(miM) showed a distinctive elongated morphology, unique
among the combinations that we used (Figure S1G).
Reasoning that some of these four factors might complement
one other, we tested three-factor (3F) combinations. Remark-
ably, within 3 days of transduction with miBM, many RFP-
positive BJ cells exhibited small, compact cell bodies with
monopolar or bipolar projections and weak bIII-tubulin expres-
sion (Figure 1C). A characteristic neuronal morphology, consist-
ing of multiple neuritic extensions and elaborate branching,
became progressively obvious when these cells were allowed
to mature for an additional 15 days (Figures 1D–1F). The majority
of these cells displayed positive immunoreactivity for the mature
neuronal markers MAP2 (55%, n = 100) (Figure 1G) and NeuN
(46%, n = 100) (Figure 1H). In contrast, we did not observe any
neuronal-like cells in cultures transduced with any other 3F
combinations (data not shown) or in control cultures where
miR-124 was replaced with scrambled, nonspecific small
RNAs (Figure 1I). Also, the addition of more factors to miBM
did not substantially improve the process. CRL2097 fibroblasts
produced similar results to BJ cells (data not shown).
An EdU incorporation assay suggested that fibroblasts
destined to become hiN cells were most likely postmitotic within
24 hr of transgene induction, and thus it is likely that hiN conver-
sion occurred in the absence of a mitotic progenitor cell stage
(Figures S1H–S1P). By dividing the number of Tuj1-positive hiN
cells on day 18 by the total number of cells in the starting fibro-
blast population, we estimated an efficiency of 4%–8% for hiN
generation from BJ or CRL2097 human fibroblast cells (Fig-
ure S1Q). Furthermore, and importantly, using a doxycycline or
cumate-inducible system, we found that expression of miBM
for 7 days was sufficient to produce hiN cells at a frequency
comparable to that of our earlier experiments (Figure 1A and
Figures S2A–S2G).
To functionally characterize hiN cells derived with miBM,
we examined their electrophysiological properties on day 25
when the vast majority of cells displayed synapsin immunoreac-
tivity (Figures 2A and 2B), a marker associated with functional
maturation of neuronal synapses. During whole-cell recording
in voltage-clamp mode, the majority of hiN cells (60%, n = 10)
exhibited rapidly inactivating inward current with a rise time of
2–3ms, followed by outward currents, most likely corresponding
to opening of voltage-dependent Na+ and K+ channels, respec-
tively (Figure 2C). The inward current was inhibited by the sodium
channel blocker tetrodotoxin (Figure 2D). In current-clampmode, the resting membrane potential averaged about 45 mV,
and with increasing time in culture the majority of cells (81%,
n = 29) fired action potentials with amplitudes of 110 mV
in response to injection of 10 to 20 pA currents (Figure 2E).
Some hiN cells (15%) exhibited spontaneous action potentials
(Figure 2F, left panel), and others (20%), repetitive trains of
evoked action potentials (Figure 2F, right panel). We also
monitored additional electrophysiological parameters, including
membrane capacitance, access resistance, and total membrane
resistance (Table S2A); these values are consistent with the
notion that the hiN cells were maturing neurons.
We next examined whether the hiN cells manifested functional
neurotransmitter properties by testing for specific markers and
corresponding ligand-gated currents. Immunostaining revealed
that about 8% of hiN cells (n = 50) were positive for the inhibitory
neurotransmitter GABA (Figures 2G and 2H), and 12% mani-
fested punctuate staining for VGAT (data not shown), a protein
involved in vesicular transport of GABA. Importantly, hiN cells
responded to exogenous application of GABA (60%, n = 5),
producing whole-cell currents (Figure 2I).
Furthermore, we recorded slowly decaying NMDA-evoked
current in 67% (n = 6) of hiN cells (Figure 2J). Moreover, a high
percentage of hiN cells displayed presynaptic properties of
excitatory glutamatergic neurons, as indicated by positive
VGLUT1 staining (44%, n = 50) (Figures 2K and 2L), a marker
for the vesicular glutamate transporter. While we observed rare
hiN cells of dopaminergic-like phenotype, as evidenced by tyro-
sine hydroxylase staining (Figures 2M and 2N), none stained
for peripherin, choline acetyltransferase, or serotonin (data not
shown).
By day 30 postinfection, patch-clamp recordings revealed
miniature excitatory postsynaptic currents (mEPSCs), indicative
of functional synapses, in 25% (n = 8) of hiN cells (Figure 2O, top
panel). These currents were sensitive to NBQX, an AMPA-type
glutamate receptor antagonist, but not bicuculline, a competitive
inhibitor of GABAA receptors (Figure 2O, bottom panel), thus
further confirming their excitatory nature. These results further
substantiate the functional neurotransmitter properties of hiN
cells derived from postnatal human fibroblasts, and collectively
provide strong evidence that the cells had become functional
neurons that generated synaptic connections.
Finally, to examine whether adult human fibroblasts could
generate hiN cells, we tested dermal fibroblasts derived from
abdominal skin of a 55-year-old Caucasian female (aHDF-1)
and breast skin of a 41-year-old Caucasian female (aHDF-2).
After confirming that these cells were free of contaminating
neural or spinal progenitor cells, neurons, or epidermal keratino-
cytes (Figures S1A and S1B), we transduced them with viruses
carrying the miBM transgenes. Similar to our observations on
postnatal fibroblasts, these adult human fibroblasts were con-
verted to hiN cells with an efficiency of 1.5%–2.9% (aHDF-1)
or 9.5%–11.2% (aHDF-2) (Figure S1Q), and displayed character-
istic mature neuronal morphology and marker gene expression
(Figures 2P–2R).
When tested on day 25 postinfection, hiN cells derived from
adult fibroblasts also exhibited rapidly inactivating Na+ currents
(47%, n = 17) and fired action potentials (12%, n = 25) (Figures 2S
and 2T). The mean action potential amplitude was 73.4 ±
18.3 mV (mean ± SEM). Values for resting membrane potential,Cell Stem Cell 9, 113–118, August 5, 2011 ª2011 Elsevier Inc. 115
Figure 2. hiN Cells from Postnatal and Adult Human Fibroblasts Show Functional Maturation and Synaptic Properties
(A and B) hiN cells, assessed 25 days postinfection, stained positively for synapsin-1.
(C) Representative traces of whole-cell currents recorded in voltage-clamp mode. Cells were hyperpolarized to 90 mV for 300 ms before depolarizing pulses
were applied to elicit Na+ and K+ currents.
(D) The inward currents could be blocked by Na+ channel blocker tetrodotoxin (TTX). CsCl was present in the patch electrode-filling solution to suppress K+
currents. Representative current traces recorded in the presence of TTX are shown at left, and the current-voltage (I/V) relationship, at right (mean + SEM, n = 13).
(E and F) Traces of evoked (E) and spontaneous (F, left panel) action potentials recorded in current-clamp mode on day 25. In other hiN cells, repetitive trains
of evoked action potentials were observed after transgene inactivation (F, right panel).
(G and H) hiN cells expressing GABA.
(I) GABA-evoked current from hiN cell at a holding potential of 80 mV.
(J–L) Other hiN cells responded to application of exogenous NMDA in the nominal absence of extracellular Mg2+ (J) and expressed glutamate transporter VGLUT
(K and L).
(M and N) hiN cell staining for tyrosine hydroxylase (TH) on day 25.
(O) Top panel: Representative traces of mEPSCs recorded at a holding potential of 80 mV in hiN cells on day 30 in culture, indicating functional synapse
formation. The insert demonstrates the rapid kinetics of these synaptic currents. Bottom panel: Spontaneous synaptic currents were reversibly inhibited by
addition of 10 mM NBQX (to block excitatory AMPA-type glutamate receptors), but not by 20 mM bicuculline (to block inhibitory GABA receptors).
(P) Representative image of live aHDF-converted hiN cells on day 18 postinfection exhibiting typical neuronal morphology and RFP fluorescence.
(Q and R) aHDF-converted hiN cells displayed mature neuronal marker MAP2 when fixed and immunostained 18 days after 3F (miBM) infection.
(S) Representative traces of whole-cell currents in voltage-clamp mode from aHDF-converted hiN cells 25 days postinfection. Cells were hyperpolarized to
90 mV for 300 ms before depolarizing pulses were applied to elicit Na+ and K+ currents.
(T) Representative action potential recorded in current-clamp mode.
(U) Day 25 aHDF-converted hiN cell displaying immunoreactivity for VGLUT antibody.
(V) Patch-clamp recording showing response of day 25 aHDF-converted hiN cell to application of exogenous NMDA in the nominal absence of Mg2+ in the bath
solution.
(W) Spontaneous synaptic currents from an aHDF hiN cell plated at high density (lower trace), reflecting mEPSCs given the composition of the intracellular and
bath solutions used in the recording (see Experimental Procedures). The magnified trace shows the rapid kinetics of an mEPSC. When plated at lower density to
isolate the cells, aHDF hiNs were synaptically silent (upper trace).
Red: RFP; green: synapsin (B), GABA (H), VGLUT (L), TH (N), MAP2 (R), and VGLUT (U); blue: DAPI stained nuclei (Q and U). Boxed areas in the left-hand panels
(A, G, and K) are shown at higher magnification in the adjacent right-hand panels (B, H, and L). Large red cells in (G), (K), (M), and (Q) are infected fibroblasts
expressing RFP that have not undergone conversion to hiN cells. (A), (G), (K), (M), (Q), and (U) are merged images. Scale bars: 20 mm. See also Figure S2 and
Table S2.
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resistance (Table S2B) were comparable to those of BJ or
CRL2097-derived hiN cells, except that the greater membrane
resistance probably reflected their more immature nature.
Moreover, many of these cells exhibited VGLUT1 immunoreac-
tivity (28%, n = 50) (Figure 2U) and NMDA-evoked responses
(60%, n = 5) (Figure 2V), thus displaying excitatory neuronal
properties. Additionally, when plated at high density, but not
low density, aHDF-hiN cells displayed excitatory synaptic
currents (43%, n = 7) (Figure 2W), reflecting functional contacts
with neighboring hiNs.
Therefore, we have demonstrated here that a combination of
miR-124, BRN2, and MYT1L can induce rapid reprogramming
of postnatal and adult human fibroblasts into functional neurons.
While other combinations of transcription factors have recently
been reported to produce neuronal-like cells from human fibro-
blasts (Pang et al., 2011) and dopaminergic neurons (Pfisterer
et al., 2011; Caiazzo et al., 2011), an important development
with our combined microRNA/transcription factor approach is
that we have been able to produce neurons with mature func-
tional synapses between adult fibroblast-derived hiNs in the
absence of other cell types.
Along these lines, in our study reprogramming was ineffective
for combinations of factors lacking miR-124. miR-124, the most
abundant microRNA in the mammalian CNS (Lagos-Quintana
et al., 2002), is markedly upregulated in differentiating and
mature neurons (Deo et al., 2006), where it modulates the activity
of major antineuronal differentiation factors, including REST/
SCP1 (Conaco et al., 2006; Visvanathan et al., 2007), PTBP1
(Makeyev et al., 2007), SOX9 (Cheng et al., 2009), and npBAF
complex (Yoo et al., 2009). Moreover, miR-124 targets more
than 1000 genes, many of which are downregulated during
neuronal differentiation (Lewis et al., 2005). Interestingly, intro-
duction of miR-124 to HeLa cells could transform their gene
expression pattern to resemble that of brain tissue (Lim et al.,
2005). However, overexpression of miR-124 by itself seems to
be insufficient to induce neurogenesis, but rather ensured that
nonneuronal genes were posttranscriptionally inhibited in
neurons (Cao et al., 2007). In line with these observations, in
our experiments miR-124 only effected neuronal reprogramming
in the presence of other key factors. The reprogramming plat-
form described here provides rapid conversion of adult cell types
directly into neurons, as opposed to more time-consuming
and labor-intensive iPSC or ESC-based methods. Our findings
also provide a technology that can use patient-specific cells
for the rapid production of models of various human neuro-
degenerative ‘‘diseases in a dish,’’ including diseases that are
only manifest later in life.
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